HUMAN CYTOMEGALOVIRUS-INFECTION OF THE MAJOR LEUKOCYTE SUBPOPULATIONS AND EVIDENCE FOR INITIAL VIRAL REPLICATION IN POLYMORPHONUCLEAR LEUKOCYTES FROM VIREMIC PATIENTS

被引:142
作者
GERNA, G
ZIPETO, D
PERCIVALLE, E
PAREA, M
REVELLO, MG
MACCARIO, R
PERI, G
MILANESI, G
机构
[1] IST RIC FARMACOL MARIO NEGRI,MILAN,ITALY
[2] POLICLIN SAN MATTEO,IRCCS,DIPARTIMENTO PEDIAT,MILAN,ITALY
[3] POLICLIN SAN MATTEO,IRCCS,CNR,IST GENET BIOCHIM & EVOLUZIONIST,MILAN,ITALY
关键词
D O I
10.1093/infdis/166.6.1236
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fourteen immunocompromised patients were examined for viremia, pp65 and p72 antigenemia, and presence of viral DNA in leukocyte fractions of polymorphonuclear leukocytes (PMNL), monocytes/macrophages (M/M), and B and T lymphocytes after purification by fluorescence-activated cell sorting. Nearly all PMNL and M/M fractions were positive for DNA and pp65 antigenemia, while p72 antigenemia was detected in 73% and 62%, respectively. The virus isolation rate was 45% from PMNL and 17% from M/M. T lymphocytes were positive for DNA in 50% of cases and for pp65 and p72 antigenemia in only 11%, while B lymphocytes were DNA-positive in 43% of samples and consistently negative for antigenemia; neither T nor B lymphocytes had virus isolated. Immediate-early (IE)1 RNA was present in 23 (85.2%) of 27 dextran-enriched DNA-positive p72-positive PMNL samples and, in sequential PMNL samples from two heart-transplanted patients, was detected during peak infection in association with p72. Thus, PMNL and M/M are the subpopulations primarily involved in HCMV infection; PMNL may undergo IE replicative events and are not merely passive carriers of phagocytized viral material.
引用
收藏
页码:1236 / 1244
页数:9
相关论文
共 29 条
[1]   REPLICATION OF HUMAN CYTOMEGALOVIRUS IN HUMAN PERIPHERAL-BLOOD T-CELLS [J].
BRAUN, RW ;
REISER, HC .
JOURNAL OF VIROLOGY, 1986, 60 (01) :29-36
[2]  
BRENNER CA, 1989, BIOTECHNIQUES, V7, P1096
[3]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]   LOCALIZATION OF HUMAN CYTOMEGALOVIRUS IN PERIPHERAL-BLOOD LEUKOCYTES BY INSITU HYBRIDIZATION [J].
DANKNER, WM ;
MCCUTCHAN, JA ;
RICHMAN, DD ;
HIRATA, K ;
SPECTOR, SA .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (01) :31-36
[5]   INTERACTION OF STRAIN AD169 AND A CLINICAL ISOLATE OF CYTOMEGALOVIRUS WITH PERIPHERAL MONOCYTES - THE EFFECT OF LIPOPOLYSACCHARIDE STIMULATION [J].
DUDDING, LR ;
GARNETT, HM .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (05) :891-896
[6]   CYTOMEGALOVIRUS-INFECTION OF HUMAN-BLOOD CELLS [J].
EINHORN, L ;
OST, A .
JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (02) :207-214
[7]  
GARNETT HM, 1982, J LAB CLIN MED, V99, P92
[8]   MONITORING OF HUMAN CYTOMEGALOVIRUS INFECTIONS AND GANCICLOVIR TREATMENT IN HEART-TRANSPLANT RECIPIENTS BY DETERMINATION OF VIREMIA, ANTIGENEMIA, AND DNAEMIA [J].
GERNA, G ;
ZIPETO, D ;
PAREA, M ;
REVELLO, MG ;
SILINI, E ;
PERCIVALLE, E ;
ZAVATTONI, M ;
GROSSI, P ;
MILANESI, G .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (03) :488-498
[9]   QUANTIFICATION OF HUMAN CYTOMEGALOVIRUS VIREMIA BY USING MONOCLONAL-ANTIBODIES TO DIFFERENT VIRAL-PROTEINS [J].
GERNA, G ;
REVELLO, MG ;
PERCIVALLE, E ;
ZAVATTONI, M ;
PAREA, M ;
BATTAGLIA, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (12) :2681-2688
[10]   COMPARISON OF DIFFERENT IMMUNOSTAINING TECHNIQUES AND MONOCLONAL-ANTIBODIES TO THE LOWER MATRIX PHOSPHOPROTEIN (PP65) FOR OPTIMAL QUANTITATION OF HUMAN CYTOMEGALOVIRUS ANTIGENEMIA [J].
GERNA, G ;
REVELLO, MG ;
PERCIVALLE, E ;
MORINI, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (05) :1232-1237